Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study

被引：28
|
作者：
de la Rubia, Javier [1 ,2 ]
Roig, Monica [1 ]
Ibanez, Angela [3 ]
Garcia, Inmaculada [5 ]
Vera, Jose A. [4 ]
Aguilar, Carlos [6 ]
del Campo, Raquel [7 ]
Gonzalez, Nicolas [8 ]
Martinez, Rafael [9 ]
Palomera, Luis [10 ]
Picon, Isabel [11 ]
Rodriguez, Juan N. [12 ]
Sanz, Miguel A. [1 ]
机构：
[1] Hosp La Fe, E-46009 Valencia, Spain
[2] Univ Catolica San Vicente Martir, Valencia, Spain
[3] Gen Hosp, Albacete, Spain
[4] Hosp Virgen Macarena, Seville, Spain
[5] Gen Hosp, Castellon de La Plana, Spain
[6] Hosp Santa Barbara, Soria, Spain
[7] Hosp Son Llatzer, Palma de Mallorca, Spain
[8] Hosp Gen Obispo Polanco, Teruel, Spain
[9] Hosp Clin San Carlos, Madrid, Spain
[10] Hosp Lozano Blesa, Zaragoza, Spain
[11] Inst Valenciano Oncol, Valencia, Spain
[12] Hosp Juan Ramon Jimenez, Huelva, Spain
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2010年 / 85卷 / 04期
关键词：
RENAL-FAILURE; PLUS DEXAMETHASONE; THALIDOMIDE; COMBINATION; THERAPY;
D O I：
10.1111/j.1600-0609.2010.01500.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：363 / 365
页数：3
相关论文
共 50 条
  • [21] Efficacy and Safety of Bortezomib in Multiple Myeloma Patients with Hepatitis B: A Multicenter Retrospective Study
    Lu, Jin
    Chen, Wen-Ming
    Geng, Chuan-Ying
    Durie, Brian G. M.
    Huang, Xiao-Jun
    CHINESE MEDICAL JOURNAL, 2016, 129 (03) : 274 - 278
  • [22] A MULTICENTER, SINGLE-ARM, OPEN-LABEL SAFETY AND QUALITY OF LIFE STUDY OF LENALIDOMIDE PLUS DEXAMETHASONE IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE MYELOMA
    Yong, K.
    Alegre Amor, A.
    Browne, P.
    Cavenagh, J.
    Dodds, T.
    Greil, R.
    Horvath, N.
    Ludwig, H.
    O'Dwyer, M.
    Oriol Rocafiguera, A.
    Prince, M.
    Taylor, K.
    Knight, R.
    Rosettani, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 392 - 392
  • [23] A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan
    Yuichi Horigome
    Masaki Iino
    Yoriko Harazaki
    Takahiro Kobayashi
    Hiroshi Handa
    Yasushi Hiramatsu
    Taiga Kuroi
    Kazuki Tanimoto
    Kosei Matsue
    Masahiro Abe
    Tadao Ishida
    Shigeki Ito
    Hiromi Iwasaki
    Junya Kuroda
    Hirohiko Shibayama
    Kazutaka Sunami
    Hiroyuki Takamatsu
    Hideto Tamura
    Toshiaki Hayashi
    Kiwamu Akagi
    Takahiro Maeda
    Takahiro Yoshida
    Ikuo Mori
    Tomohiro Shinozaki
    Shinsuke Iida
    Annals of Hematology, 2024, 103 : 475 - 488
  • [24] A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan
    Horigome, Yuichi
    Iino, Masaki
    Harazaki, Yoriko
    Kobayashi, Takahiro
    Handa, Hiroshi
    Hiramatsu, Yasushi
    Kuroi, Taiga
    Tanimoto, Kazuki
    Matsue, Kosei
    Abe, Masahiro
    Ishida, Tadao
    Ito, Shigeki
    Iwasaki, Hiromi
    Kuroda, Junya
    Shibayama, Hirohiko
    Sunami, Kazutaka
    Takamatsu, Hiroyuki
    Tamura, Hideto
    Hayashi, Toshiaki
    Akagi, Kiwamu
    Maeda, Takahiro
    Yoshida, Takahiro
    Mori, Ikuo
    Shinozaki, Tomohiro
    Iida, Shinsuke
    ANNALS OF HEMATOLOGY, 2024, 103 (02) : 475 - 488
  • [25] LENALIDOMIDE IN COMBINATION WITH LOW-DOSE DEXAMETHASONE IN RELAPSE/ REFRACTORY MULTIPLE MYELOMA: A RETROSPECTIVE STUDY
    Firatli-Tuglular, T.
    Noyan-Atalay, F.
    Eser, A.
    Toptas, T.
    Pepedil, F.
    Kaygusuz-Atagunduz, I.
    Adiguzel, C.
    HAEMATOLOGICA, 2013, 98 : 614 - 615
  • [26] EFFICACY AND SAFETY OF LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A REAL LIFE EXPERIENCE
    Soyer, N.
    Patir, P.
    Uysal, A.
    Duran, M.
    Unal, H. D.
    Tombuloglu, M.
    Sahin, F.
    Vural, F.
    Saydam, G.
    LEUKEMIA RESEARCH, 2016, 49 : S36 - S36
  • [27] Treatment with lenalidomide and dexamethasone in patients with multiple myeloma and renal impairment
    Dimopoulos, Meletios A.
    Terpos, Evangelos
    Goldschmidt, Hartmut
    Alegre, Adrian
    Mark, Tomer
    Niesvizky, Ruben
    CANCER TREATMENT REVIEWS, 2012, 38 (08) : 1012 - 1019
  • [28] Safety and efficacy of bortezomib in multiple myeloma patients with renal failure requiring dialysis.
    Chanan-Khan, AA
    Richardson, P
    Lonial, S
    Siegel, D
    Jagannath, S
    Mehta, J
    Doran, J
    Singhal, S
    BLOOD, 2005, 106 (11) : 716A - 717A
  • [29] Safety and Efficacy of the Combination of Selinexor, Lenalidomide and Dexamethasone (SRd) in Patients with Newly Diagnosed Multiple Myeloma
    White, Darrell J.
    Lentzsch, Suzanne
    Gasparetto, Cristina
    Bahlis, Nizar
    Chen, Christine I.
    Lipe, Brea C.
    Schiller, Gary J.
    Tuchman, Sascha A.
    Sutherland, Heather J.
    Kotb, Rami
    Leblanc, Richard
    Sebag, Michael
    Venner, Christopher P.
    Callander, Natalie Scott
    Bensinger, William I.
    Sheehan, Heidi
    Chai, Yi
    Kai, Kazuharu
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael G.
    Baljevic, Muhamed
    BLOOD, 2019, 134
  • [30] A Multicenter Open Label Phase II Study of Pomalidomide, Cyclophosphamide and Dexamethasone in Relapse Multiple Myeloma Patients Initially Treated with Lenalidomide, Bortezomib and Dexamethasone
    Garderet, Laurent
    Kuhnowski, Frederique
    Mary, Jean Yves
    Roussel, Murielle
    Escoffre-Barbe, Martine
    Lafon, Ingrid
    Facon, Thierry
    Karlin, Lionel
    Perrot, Aurore
    Moreau, Philippe
    Marit, Gerald
    Stoppa, Anne-Marie
    Marolleau, Jean-Pierre
    Chaleteix, Carine
    Tiab, Mourad
    Araujo, Carla
    Lenain, Pascal
    Macro, Margaret
    Voog, Eric
    Benboubker, Lofti
    Allangba, Olivier
    Jourdan, Eric
    Mohty, Mohamad
    Loiseau, Herve Avet
    Mathiot, Claire
    Attal, Michel
    BLOOD, 2017, 130
12345